• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌药物使用与最多数量的多重耐药铜绿假单胞菌之间的关系:一项 10 年研究。

Relationship between antimicrobial use and the highest number of multidrug-resistant-Pseudomonas aeruginosa: a 10-year study.

机构信息

Universidade Federal de Uberlândia, Minas Gerais. Institute of Biomedical Sciences, Laboratory of Molecular Microbiology, Uberlândia-Minas Gerais, Brazil.

Clinical Hospital, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.

出版信息

J Infect Dev Ctries. 2024 Aug 31;18(8):1227-1232. doi: 10.3855/jidc.18400.

DOI:10.3855/jidc.18400
PMID:39288381
Abstract

INTRODUCTION

Multi-drug-resistant (MDR) Pseudomonas aeruginosa is a dangerous pathogen causing nosocomial infection, particularly in low- and middle-income countries like Brazil. This retrospective study at a Brazilian university hospital examined the relationship between antimicrobial use and MDR-P. aeruginosa.

METHODOLOGY

Data was collected from 358 patients with non-repetitive P. aeruginosa infections from 2009 to 2019. Antibiotic use was measured in grams and expressed as defined daily dose (DDD) per 1000 patient-days for meropenem, imipenem, polymyxin, and tigecycline.

RESULTS

Extensively drug-resistant (XDR) P. aeruginosa occurred in 36.1%, and MDR in 32.6% of cases. Risk factors for XDR infection were hospitalization prior to infection (OR = 0.9901), intensive care unit (ICU) admission (OR = 0.4766), previous antibiotic use (OR = 1.4417), and use of cefepime (OR = 0.3883). Over the ten-year period, utilization of the monitored antibiotics increased, and there was a positive correlation between the rise in MDR-P. aeruginosa and the consumption of ceftriaxone, imipenem, meropenem, and polymyxin B. The 30-day mortality rate was 40.0% for all patients and 41.0% for those infected with XDR-P. aeruginosa.

CONCLUSIONS

This study highlights the negative impact of the indiscriminate use of antimicrobials, which has led to a significant increase in multidrug-resistant P. aeruginosa strains in hospitals.

摘要

简介

多重耐药(MDR)铜绿假单胞菌是一种危险的病原体,可引起医院感染,尤其是在巴西等中低收入国家。巴西一家大学医院的这项回顾性研究调查了抗菌药物使用与 MDR-P. aeruginosa 之间的关系。

方法

从 2009 年至 2019 年,收集了 358 例非重复铜绿假单胞菌感染患者的数据。将美罗培南、亚胺培南、多黏菌素和替加环素的使用量以克为单位进行测量,并表示为每 1000 个患者天的限定日剂量(DDD)。

结果

广泛耐药(XDR)铜绿假单胞菌的发生率为 36.1%,MDR 为 32.6%。XDR 感染的危险因素包括感染前住院(OR=0.9901)、入住重症监护病房(ICU)(OR=0.4766)、既往抗生素使用(OR=1.4417)和头孢吡肟使用(OR=0.3883)。在十年期间,监测抗生素的使用量增加,MDR-P. aeruginosa 的上升与头孢曲松、亚胺培南、美罗培南和多黏菌素 B 的消耗呈正相关。所有患者的 30 天死亡率为 40.0%,XDR-P. aeruginosa 感染者的死亡率为 41.0%。

结论

本研究强调了抗生素滥用的负面影响,这导致医院中多药耐药铜绿假单胞菌菌株显著增加。

相似文献

1
Relationship between antimicrobial use and the highest number of multidrug-resistant-Pseudomonas aeruginosa: a 10-year study.抗菌药物使用与最多数量的多重耐药铜绿假单胞菌之间的关系:一项 10 年研究。
J Infect Dev Ctries. 2024 Aug 31;18(8):1227-1232. doi: 10.3855/jidc.18400.
2
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.埃塞俄比亚东北部德西综合专科医院住院患者中不动杆菌和铜绿假单胞菌医院感染的耐药谱及相关因素。一项横断面研究。
PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021.
3
Risk factors for hospitalized patients with resistant or multidrug-resistant infections: a systematic review and meta-analysis.住院患者耐多药或多重耐药感染的危险因素:系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2018 Jul 4;7:79. doi: 10.1186/s13756-018-0370-9. eCollection 2018.
4
Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.2011-2018 年波兰大学重症监护病房医源性感染相关的微生物因素特征,包括多药耐药病原体和抗生素使用情况。
Int J Environ Res Public Health. 2020 Sep 23;17(19):6943. doi: 10.3390/ijerph17196943.
5
[Nosocomial infections caused by multiresistant Pseudomonas aeruginosa (carbapenems included): predictive and prognostic factors. A prospective study (2016-2017))].[多重耐药铜绿假单胞菌(包括碳青霉烯类耐药菌)引起的医院感染:预测和预后因素。一项前瞻性研究(2016 - 2017年)]
Rev Esp Quimioter. 2018 Apr;31(2):123-130. Epub 2018 Mar 21.
6
The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.铜绿假单胞菌对抗生素的耐药特性及血清型分布情况
Medicina (Kaunas). 2007;43(1):36-42.
7
Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-year survey.葡萄牙一家中心医院铜绿假单胞菌临床分离株中的多重耐药和广泛耐药:10年调查
Microb Drug Resist. 2015 Apr;21(2):194-200. doi: 10.1089/mdr.2014.0137. Epub 2014 Nov 5.
8
Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption.重症监护病房中的铜绿假单胞菌:流行情况、耐药谱和抗菌药物消耗。
Rev Soc Bras Med Trop. 2019 Dec 20;53:e20180498. doi: 10.1590/0037-8682-0498-2018. eCollection 2019.
9
Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.铜绿假单胞菌所致重症监护病房获得性肺炎(包括和不包括多重耐药)。
J Infect. 2017 Feb;74(2):142-152. doi: 10.1016/j.jinf.2016.11.008. Epub 2016 Nov 16.
10
Virulence factors and integrons are associated with MDR and XDR phenotypes in nosocomial strains of Pseudomonas aeruginosa in a Venezuelan university hospital.在委内瑞拉一家大学医院的医院内铜绿假单胞菌菌株中,毒力因子和整合子与多重耐药和广泛耐药表型相关。
Rev Inst Med Trop Sao Paulo. 2019;61:e20. doi: 10.1590/S1678-9946201961020. Epub 2019 Apr 4.